GMAB · Genmab A/S

Summary

Genmab A/S disclosed that Orbis Investment Management Limited now holds 5.08% of its share capital and voting rights, crossing the 5% threshold.

Key takeaways

• Orbis Investment Management Limited increased its stake to 5.08% of Genmab's voting rights, crossing the 5% threshold.
• The notification was made under the Danish Capital Markets Act, indicating a major shareholder event.
• The ultimate controlling entity is Allan & Gill Gray Foundation, holding 5.08% indirectly through subsidiaries.
• Previous holding was 4.85%, showing a net increase of 0.23% in voting rights.